Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Mazzetta

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biometrics|May 16, 2007
On smoothing trends in population index modelingChiara Mazzetta, Steve Brooks, Stephen N Freeman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Intravascular ultrasound based dose assessment in endovascular brachytherapyGianpiero Catalano, Vittorio Tamburini, Antonio Colombo, et al.
Ecancermedicalscience|September 10, 2016
Maps and atlases of cancer mortality: a review of a useful tool to trigger new questionsAlberto d'Onofrio, Chiara Mazzetta, Chris Robertson, et al.
Tumori|March 15, 2005
Androgen ablation therapy does not increase the risk of late morbidity following 3D-conformal radiotherapy of organ-confined prostate cancer: the experience of the European Institute of OncologyCarlo Greco, Simona Castiglioni, Andrei Fodor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancerCarlo Greco, Chiara Mazzetta, Federica Cattani, et al.
BJU International|December 22, 2004
The prevalence of urinary incontinence in community-dwelling married women: a matter of definitionVera Vandoninck, Bart L H Bemelmans, Chiara Mazzetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancerPier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, et al.
BJU International|February 23, 2007
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studiesChris Robertson, Carol L Link, Erol Onel, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomasLisa Bodei, Daria Handkiewicz-Junak, Chiara Grana, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patientsBarbara A Jereczek-Fossa, Anna Morra, Filippo DeBraud, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biometrics|May 16, 2007
On smoothing trends in population index modelingChiara Mazzetta, Steve Brooks, Stephen N Freeman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Intravascular ultrasound based dose assessment in endovascular brachytherapyGianpiero Catalano, Vittorio Tamburini, Antonio Colombo, et al.
Ecancermedicalscience|September 10, 2016
Maps and atlases of cancer mortality: a review of a useful tool to trigger new questionsAlberto d'Onofrio, Chiara Mazzetta, Chris Robertson, et al.
Tumori|March 15, 2005
Androgen ablation therapy does not increase the risk of late morbidity following 3D-conformal radiotherapy of organ-confined prostate cancer: the experience of the European Institute of OncologyCarlo Greco, Simona Castiglioni, Andrei Fodor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancerCarlo Greco, Chiara Mazzetta, Federica Cattani, et al.
BJU International|December 22, 2004
The prevalence of urinary incontinence in community-dwelling married women: a matter of definitionVera Vandoninck, Bart L H Bemelmans, Chiara Mazzetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancerPier Francesco Ferrucci, Cristina Rabascio, Chiara Mazzetta, et al.
BJU International|February 23, 2007
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studiesChris Robertson, Carol L Link, Erol Onel, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomasLisa Bodei, Daria Handkiewicz-Junak, Chiara Grana, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 9, 2004
Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patientsBarbara A Jereczek-Fossa, Anna Morra, Filippo DeBraud, et al.
Pageof 1